ARDC Research Link Australia Research Link Australia   BETA Research
Link
Australia
  • ARDC Newsletter Subscribe
  • Contact Us
  • Home
  • About
  • Feedback
  • Explore Collaborations
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation
  • Researcher
  • Funded Activity
  • Organisation

Need help searching? View our Search Guide.

Advanced Search

Current Selection
Research Topic : conjugation
Clear All
Filter by Field of Research
Pharmacology and Pharmaceutical Sciences (3)
Pharmacology and Pharmaceutical Sciences not elsewhere classified (2)
Applied immunology (incl. antibody engineering xenotransplantation and t-cell therapies) (1)
Autoimmunity (1)
Basic Pharmacology (1)
Biochemistry and Cell Biology not elsewhere classified (1)
Chemotherapy (1)
Medical Biotechnology not elsewhere classified (1)
Medical biochemistry - lipids (1)
Filter by Socio-Economic Objective
Search did not return any results.
Filter by Funding Provider
National Health and Medical Research Council (17)
Filter by Status
Closed (17)
Filter by Scheme
NHMRC Project Grants (11)
Project Grants (4)
Development Grants (1)
NHMRC Postgraduate Scholarships (1)
Filter by Country
Australia (2)
Filter by Australian State/Territory
NSW (1)
SA (1)
  • Researchers (0)
  • Funded Activities (17)
  • Organisations (0)
  • Funded Activity

    Transmembrane Peptide - Lipid Interactions

    Funder
    National Health and Medical Research Council
    Funding Amount
    $42,498.00
    More information
    Funded Activity

    The Effects Of Unstable Degradation Products Of Certain Drugs In The Body

    Funder
    National Health and Medical Research Council
    Funding Amount
    $769,147.00
    More information
    Funded Activity

    A Study Of The Genes In The Golden Staph Organism

    Funder
    National Health and Medical Research Council
    Funding Amount
    $91,783.00
    More information
    Funded Activity

    A Novel Metabolic Role For UDP Glycosyltransferase 8 (UGT8)

    Funder
    National Health and Medical Research Council
    Funding Amount
    $419,144.00
    Summary
    The UDP glycosyltransferases (UGTs) are a family of enzymes that remove drugs and toxins from the human body as well as control levels of naturally produced molecules such as bile acids and hormones. We found that a new member of this family called UGT8 processes bile acids in the kidney and intestine and can affect how bile acids act to regulate metabolism. Our studies uncover new roles for bile acids in liver, kidney and gut health and in metabolic disorders such as diabetes and obesity.
    More information
    Funded Activity

    The Effects Of Unstable Degradation Products Of Certain Drugs In The Body

    Funder
    National Health and Medical Research Council
    Funding Amount
    $635,188.00
    More information
    Funded Activity

    Regulation Of Drug Detoxifying UDP Glucuronosyltransferases

    Funder
    National Health and Medical Research Council
    Funding Amount
    $590,945.00
    Summary
    Some organs in the body are particularly sensitive to fat-soluble chemicals taken in from the environment or present in food. They are also sensitive to hormones and other small molecule products of metabolism. Controlling the levels of these potentially toxic chemicals is essential in order to maintain the health of the organ. In this work we will investigate the regulation of detoxifying enzymes that protect these organs by inactivating and hastening the elimination of fat-soluble chemicals.
    More information
    Funded Activity

    Characterization Of The Novel Drug And Xenobiotic Metabolizing UGT3A Enzyme Family

    Funder
    National Health and Medical Research Council
    Funding Amount
    $578,352.00
    Summary
    The elimination of chemicals made in the body or from environmental sources is essential for the maintenance of good health and the prevention of debilitating diseases. We have discovered two enzymes that use glucose and other sugars to detoxify fat-soluble chemicals. In this project we will study how these enzymes work and how they are regulated in the body. With this knowledge, we may be able to target the processes of drug and chemical detoxification to make them more efficient.
    More information
    Funded Activity

    Investigating Novel Antibody Drug Conjugates For Treating Lung Cancer

    Funder
    National Health and Medical Research Council
    Funding Amount
    $663,447.00
    Summary
    Chemotherapy is first-line treatment for advanced lung cancer patients. Most patients inevitably develop chemotherapy resistance. To increase chemotherapy effectiveness, we are developing a new antibody-based approach to target cancer cells that die because of chemotherapy. The antibody is armed with a very potent drug released specifically at the cancer to cause death of surrounding, chemotherapy-resistant cells. Killing these cells may reduce rebound cancer growth and cause an immune reaction.
    More information
    Funded Activity

    Characterisation Of Enzymes That Break Down Drugs In Human Liver

    Funder
    National Health and Medical Research Council
    Funding Amount
    $122,739.00
    More information
    Funded Activity

    Molecular Determinants Of UDP Glucuronosyltransferase 1A3 And 1A4 Expression

    Funder
    National Health and Medical Research Council
    Funding Amount
    $516,078.00
    Summary
    Enzymes in the liver and gastrointestinal tract have a crucial role in protecting against the toxic effects of fat-soluble chemicals. Two of these enzymes called UGT1A3 and UGT1A4 have a special role in protecting against drugs and toxins that contain nitrogen groups. The levels of these two enzymes in the liver and gut vary extensively between individuals. In this project we will determine how the levels of these enzymes are controlled and what is the cause of this variability between individua .... Enzymes in the liver and gastrointestinal tract have a crucial role in protecting against the toxic effects of fat-soluble chemicals. Two of these enzymes called UGT1A3 and UGT1A4 have a special role in protecting against drugs and toxins that contain nitrogen groups. The levels of these two enzymes in the liver and gut vary extensively between individuals. In this project we will determine how the levels of these enzymes are controlled and what is the cause of this variability between individuals. This will help us predict those individuals who are more at risk from the adverse effects of nitrogen-containing drugs and from the toxic effects of chemicals in the diet or the environment. This project will also help us develop methods to increase the levels of these protective enzymes and help reduce the effects of exposure to toxic chemicals.
    Read more Read less
    More information

    Showing 1-10 of 17 Funded Activites

    • 1
    • 2
    Advanced Search

    Advanced search on the Researcher index.

    Advanced search on the Funded Activity index.

    Advanced search on the Organisation index.

    National Collaborative Research Infrastructure Strategy

    The Australian Research Data Commons is enabled by NCRIS.

    ARDC CONNECT NEWSLETTER

    Subscribe to the ARDC Connect Newsletter to keep up-to-date with the latest digital research news, events, resources, career opportunities and more.

    Subscribe

    Quick Links

    • Home
    • About Research Link Australia
    • Product Roadmap
    • Documentation
    • Disclaimer
    • Contact ARDC

    We acknowledge and celebrate the First Australians on whose traditional lands we live and work, and we pay our respects to Elders past, present and emerging.

    Copyright © ARDC. ACN 633 798 857 Terms and Conditions Privacy Policy Accessibility Statement
    Top
    Quick Feedback